Figure 2.
Proliferation and IFNγ production by Vγ9Vδ2 cells from cancer patients before and after treatment with zoledronic acid. PBMCs were cultured at 37°C, in the presence of 5% CO2, at 106/mL in 96-well flat-bottomed plates (0.2 mL/well), with isopentenylpyrophosphate (IPP; Sigma Chemical, St Louis, MO; 100 μM/mL final concentration) and 20 U/mL final concentration human recombinant IL-2 (▪) or with IL-2 alone as a control (□). Proliferation (A) was measured 7 days later by adding 1 μCi/well (0.037 MBq) [3H]thymidine (Amersham, Arlington Heights, IL) during the last 6 hours of culture. Cells were then harvested and [3H]thymidine incorporation was measured with a liquid scintillation β-counter. Results are expressed as mean counts per minute (cpm) of triplicate wells ± standard deviation (SD). IFNγ levels in the 48-hour culture supernatants (B) were assessed by 2 monoclonal antibodies (mAbs) sandwich enzyme-linked immunosorbent assay (ELISA) assay following the manufacturer's recommendations (R&D Systems, Minneapolis, MN).